How to use Technologies offered
A search for a cancer, preclinical stage, synthetic opportunity would use the selection "Therapeutics, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.
Selection of 'Enabling Technology, Platform Technology' in 'Sector' will identify all kinds of research technologies that can be used in more areas of life sciences than pharmaceuticals only.
Each technology profile gives the name of a company or academic institute as source of the offer, and a link allowing to contact the potential licensor. In most cases a profile includes a pdf covering the available non-confidential information as well as detailed contact data.
Registered users can create non-public notifications profiles which will inform them about new 'Technologies Offered' entries fitting their needs as specified. In addition these profiles allow them to filter the available information more comfortably.
Vitronectin XF™, a low cost, xenobiotic-free substrate for stem cell expansion and differentiation.
Primorigen's Vitronectin XF™ is a high quality, low cost, user-friendly replacement for BD Matrigel™ for stem cell culture and stem cell differentiation. Vitronectin XF™ is a defined, recombinant fusion protein containing the full length human vitronectin sequence, expressed in human cells under chemically defined, xeno-free conditions. Cost/well under Matrigel, usable at room temperatures, available as evaluation kit.
- Maintains pluripotency and normal karyotype
- Maintains 'normal' colony morphology
- Supports differentiation
- Easy to use
To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login
Please click here to log in to view the complete profile.